Imugene Ltd has released a press release.
Appendix 4C - quarterly
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Imugene
- Imugene announces clinical milestone for HER-Vaxx
- Imugene Oncolytic Virus Presentation at AACR 2021 Meeting
- Final Highest Dose in Phase 1 Clinical Trial of PD-VAXX
- S&P DJI Announces March 2021 Quarterly Rebalance
- Imugene to Present HER-Vaxx Phase 2 Data at AACR21 Meeting
Later from Imugene
- Prestigious Research Journal Publish HER-Vaxx Phase 1B Data
- Investor Presentation
- FDA ind approval of new oncolytic virotherapy checkvacc
- Appendix 4C - Quarterly Report
- Imugene completes $90 M placement and launches $5 M SPP
Follow Imugene into a list and get an email when it puts out news.
Follow Imugene